Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages

Takashi Ichiyama1, Masanari Hasegawa, Kunio Hashimoto

  • 1Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan. ichiyama@yamaguchi-u.ac.jp

Abstract

Insights

Cysteinyl leukotrienes (CysLTs) stimulate macrophage inflammatory protein (MIP) production in human monocytes via the CysLT(1) receptor and extracellular signal-regulated kinase (ERK) pathway. This finding clarifies inflammatory signaling in monocytes/macrophages.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta are key mediators of inflammation and monocyte recruitment.
  • These chemokines interact with monocytes/macrophages expressing the cysteinyl leukotriene 1 (CysLT(1)) receptor.

Purpose of the Study:

  • To investigate the role of CysLTs in stimulating MIP-1alpha and MIP-1beta production.
  • To elucidate the receptor and intracellular signaling pathways involved in CysLT-induced MIP production.

Main Methods:

  • THP-1 cells and peripheral blood mononuclear cells (PBMCs) were stimulated with CysLTs (LTC(4), LTD(4), LTE(4)).
  • MIP-1alpha and MIP-1beta production and mRNA expression were quantified using ELISA and PCR.
  • The effects of pranlukast (CysLT(1) receptor antagonist) and mitogen-activated protein kinase (MAPK) inhibitors were assessed.

Main Results:

  • CysLTs significantly induced MIP-1alpha and MIP-1beta production in both THP-1 cells and PBMCs.
  • LTD(4) stimulation increased MIP-1alpha and MIP-1beta mRNA levels in THP-1 cells.
  • Pranlukast inhibited LTD(4)-induced MIP production, and an ERK inhibitor attenuated this induction, while JNK and p38 inhibitors had no effect.

Conclusions:

  • CysLTs induce MIP-1alpha and MIP-1beta production in human monocytes/macrophages.
  • This induction is mediated by the CysLT(1) receptor and the extracellular signal-regulated kinase (ERK) signaling pathway.

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Inflammation01:38

Inflammation

Overview
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...